BioAge Labs to Participate in Upcoming Investor Conferences in December 2024
BioAge Labs will present at two investor conferences in December 2024, focusing on aging-related metabolic disease therapies.Quiver AI SummaryBioAge Labs, a clinical-stage biopharmaceutical company focused...
Prediction: These 2 Stocks Could Soar in 2025
The key word here is "could."
GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom
The future of the weight loss market might not revolve around GLP-1 drugs.
Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock
BioAge Labs is the latest pharmaceutical company looking to make waves in the weight loss realm.
Three Biotech Startups Plan $400 Million U.S. IPOs Amid Sector Resurgence
Three healthcare startups are aiming to raise up to $400 million through their U.S. initial public offerings, highlighting a strong resurgence in the biotech sector after a two-year downturn. September...
2 Next-Gen Weight Loss Stocks That Are Worth Buying Right Now
One of these businesses is a risky play, but the other is very likely to succeed.